Mark S. Schroeder - 11 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
EVP, Pres Diagnostics & COO
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
11 Feb 2026
Net transactions value
-$75,082
Form type
4
Filing time
13 Feb 2026, 13:13:53 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schroeder Mark S EVP, Pres Diagnostics & COO 531 SOUTH SPRING STREET, BURLINGTON /s/ Kathryn W. Kyle, Attorney-in-Fact for Mark S. Schroeder 13 Feb 2026 0001793112

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +806 +14% 6,732 11 Feb 2026 Direct F1
transaction LH Common Stock Tax liability $75,082 -259 -3.8% $289.89 6,473 11 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -806 -25% $0.000000 2,358 11 Feb 2026 Common Stock 806 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.
F4 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.